HR 6977 · 118th Congress
Independent Drug Value Assessment Act of 2024
This bill creates a new system where the federal government will hire independent organizations to evaluate whether newly approved drugs are actually worth their price tags. Right now, pharmaceutical companies essentially set their own prices with little government oversight of whether those prices match the actual…
- Sponsor
- Nadler, Jerrold (D-NY)
- Introduced
- 2024-01-11
- Policy area
- Health
- Latest action
- Referred to the Subcommittee on Health.
Digging through Congress... 🔍